| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |